{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:29:04Z","timestamp":1786994944868,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24304-0"],"award-info":[{"award-number":["2017\/24304-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus Universitets Forskningsfond","doi-asserted-by":"publisher","award":["AUFF-E\u22122020-7-1 9"],"award-info":[{"award-number":["AUFF-E\u22122020-7-1 9"]}],"id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R366-2021-255"],"award-info":[{"award-number":["R366-2021-255"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.neuropharm.2024.109870","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T05:58:13Z","timestamp":1708667893000},"page":"109870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression."],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6502","authenticated-orcid":false,"given":"Luana Barreto","family":"Domingos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9842-8114","authenticated-orcid":false,"given":"Heidi Kaastrup","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-0776","authenticated-orcid":false,"given":"Nicole Rodrigues","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-4901","authenticated-orcid":false,"given":"Michaela D.","family":"Filiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Lade","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-7778","authenticated-orcid":false,"given":"Francisco Silveira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e2mia","family":"Joca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine\u2019s mechanism of action: a path to rapid-acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress. Anxiety"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109870_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tins.2011.03.003","article-title":"Supply and demand for endocannabinoids","volume":"34","author":"Alger","year":"2011","journal-title":"Trends Neurosci."},{"issue":"43","key":"10.1016\/j.neuropharm.2024.109870_bib3","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of \u03c9-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.109870_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainresbull.2020.07.022","article-title":"Rapid acting antidepressants in the mTOR pathway: current evidence","volume":"163","author":"Athira","year":"2020","journal-title":"Brain Res. Bull."},{"issue":"7354","key":"10.1016\/j.neuropharm.2024.109870_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13041-016-0259-6","article-title":"Orchestrated activation of mGluR5 and CB1 promotes neuroprotection","volume":"9","author":"Batista","year":"2016","journal-title":"Mol. Brain"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109870_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/bdi.12436","article-title":"Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling","volume":"18","author":"Beurel","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2024.109870_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2012.00013","article-title":"A pivotal role of GSK-3 in synaptic plasticity","volume":"5","author":"Bradley","year":"2012","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood-brain barrier, and brain disposition","volume":"12","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109870_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109870_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002690","article-title":"Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity","volume":"15","author":"Carrillo-Roa","year":"2017","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coph.2003.10.004","article-title":"Neurotrophic effects of antidepressant drugs","volume":"4","author":"Castr\u00e9n","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109870_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.109870_bib14","first-page":"19","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm. J."},{"key":"10.1016\/j.neuropharm.2024.109870_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euroneuro.2020.11.008","article-title":"The rat hippocampal gliovascular system following one week vortioxetine and fluoxetine","volume":"42","author":"Chen","year":"2021","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109870_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.euroneuro.2015.12.018","article-title":"Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat Hippocampus","volume":"26","author":"Chen","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"10128","key":"10.1016\/j.neuropharm.2024.109870_bib17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109870_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","article-title":"Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study","volume":"168","author":"Deschwanden","year":"2011","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tins.2011.11.004","article-title":"Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents","volume":"35","author":"Duman","year":"2012","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1471-4159.2001.00300.x","article-title":"Reduced activation and expression of ERK1\/2 MAP kinase in the post-mortem brain of depressed suicide subjects","volume":"77","author":"Dwivedi","year":"2001","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109870_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12031-011-9515-5","article-title":"The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression","volume":"45","author":"First","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109870_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109870_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bpsgos.2021.12.009","article-title":"Antidepressant response and stress resilience are promoted by CART peptides in GABAergic neurons of the anterior cingulate cortex","volume":"3","author":"Funayama","year":"2023","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.neuropharm.2024.109870_bib26","series-title":"Marihuana and Medicine","first-page":"91","article-title":"Absorption, distribution, and biotransformation of the cannabinoids","author":"Harvey","year":"1999"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuint.2005.11.012","article-title":"Brain 5-HT synthesis in the flinders sensitive line rat model of depression: an autoradiographic study","volume":"48","author":"Hasegawa","year":"2006","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109870_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109870_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179290","article-title":"Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: a qualitative study","volume":"12","author":"Ho","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib30","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/bcp.12845","article-title":"New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs","volume":"82","author":"Ign\u00e1cio","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109870_bib31","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109870_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*power software","volume":"18","author":"Kang","year":"2021","journal-title":"J. Educ. Eval. Health Prof."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5694\/j.1326-5377.2007.tb00838.x","article-title":"Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?","volume":"186","author":"Keks","year":"2007","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.neuropharm.2024.109870_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuint.2019.01.023","article-title":"Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and Hippocampus of the flinders sensitive line rodent model of depression","volume":"125","author":"Kirkedal","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.109870_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107684","article-title":"Ketamine-induced regulation of TrkB-gsk3\u03b2 signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites","volume":"157","author":"Kohtala","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109870_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.brainresbull.2012.01.010","article-title":"Reduced metabotropic glutamate receptor 5 in the flinders sensitive line of rats, an animal model of depression: an autoradiographic study","volume":"87","author":"Kova\u010devi\u0107","year":"2012","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2008.06.003","article-title":"AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli","volume":"64","author":"Krishnan","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109870_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1124214","article-title":"Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma","volume":"14","author":"Leineweber","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5994","key":"10.1016\/j.neuropharm.2024.109870_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.109870_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-ht1a receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrn753","article-title":"The molecular basis of CaMKII function in synaptic and behavioural memory","volume":"3","author":"Lisman","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109870_bib42","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109870_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000826","article-title":"CaMKII controls neuromodulation via neuropeptide gene expression and axonal targeting of neuropeptide vesicles","volume":"18","author":"Moro","year":"2020","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib46","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3390\/biomedicines10081853","article-title":"Single and repeated exposure to cannabidiol differently modulate BDNF expression and signaling in the cortico-striatal brain network","volume":"10","author":"Mottarlini","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2024.109870_bib47","series-title":"Synaptic Vesicles: Methods And Protocols, Methods in Molecular Biology","first-page":"89","article-title":"A guide to analysis of relative synaptic protein abundance by quantitative fluorescent western blotting","author":"M\u00fcller","year":"2022"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpsychires.2009.11.008","article-title":"Early-life stress and antidepressant treatment involve synaptic signaling and erk kinases in a gene-environment model of depression","volume":"44","author":"Musazzi","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.109870_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104940","article-title":"Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors","volume":"159","author":"Navarro","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/mol.116.104372","article-title":"Dissecting the signaling pathways involved in the crosstalk between metabotropic glutamate 5 and cannabinoid type 1 receptors","volume":"90","author":"Olmo","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109870_bib51","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-3223(86)90007-7","article-title":"Selective breeding for increased cholinergic function: development of a new animal model of depression","volume":"21","author":"Overstreet","year":"1986","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109870_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01958920","article-title":"Genetic and pharmacological models of cholinergic supersensitivity and affective disorders","volume":"44","author":"Overstreet","year":"1988","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0149-7634(05)80230-1","article-title":"The flinders sensitive line rats: a genetic animal model of depression","volume":"17","author":"Overstreet","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"\u2018The flinders sensitive line rat model of depression\u201425 Years and still producing\u2019 ed. Lynette C. Daws","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1017\/neu.2019.25","article-title":"Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression","volume":"31","author":"Pereira","year":"2019","journal-title":"Acta Neuropsychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","article-title":"Prefrontal cortex and depression","volume":"47","author":"Pizzagalli","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109870_bib59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"Planchez","year":"2019","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109870_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2008.05.003","article-title":"Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress","volume":"31","author":"Qi","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109870_bib61","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/sj.npp.1301345","article-title":"Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-c\u03b3 signaling pathways in mouse brain","volume":"32","author":"Rantam\u00e4ki","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109870_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","article-title":"Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala","volume":"23","author":"R\u00e9us","year":"2011","journal-title":"Acta Neuropsychiatr."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109870_bib63","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1177\/0269881119872173","article-title":"Antidepressant-like effect induced by P2X7 receptor blockade in FSL rats is associated with BDNF signalling activation","volume":"33","author":"Ribeiro","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109870_bib64","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.109870_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108679","article-title":"Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects","volume":"195","author":"Sartim","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109870_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109870_bib67","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/npp.2010.114","article-title":"Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models","volume":"35","author":"Schmidt","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109870_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.physbeh.2018.12.019","article-title":"Effects of cannabidiol in males and females in two different rat models of depression","volume":"201","author":"Shbiro","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2024.109870_bib69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchemneu.2019.04.006","article-title":"Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms","volume":"98","author":"Silote","year":"2019","journal-title":"J. Chem. Neuroanat."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109870_bib70","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ph14121269","article-title":"Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12640-017-9708-y","article-title":"Changes in the brain endocannabinoid system in rat models of depression","volume":"31","author":"Smaga","year":"2017","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109870_bib72","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0028-3908(02)00062-X","article-title":"Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain Hippocampus","volume":"42","author":"Smia\u0142owska","year":"2002","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109870_bib73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(01)01182-7","article-title":"Receptor-dependent formation of endogenous cannabinoids in cortical neurons","volume":"425","author":"Stella","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109870_bib74","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1007\/s12035-019-1613-3","article-title":"S-ketamine reverses hippocampal dendritic spine deficits in flinders sensitive line rats within 1 h of administration","volume":"56","author":"Treccani","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"11\u201312","key":"10.1016\/j.neuropharm.2024.109870_bib75","article-title":"Antidepressant treatment effects on hippocampal protein turnover: molecular and spatial insights from mass spectrometry","volume":"22","author":"Turck","year":"2022","journal-title":"Proteomics"},{"issue":"24","key":"10.1016\/j.neuropharm.2024.109870_bib76","doi-asserted-by":"crossref","first-page":"RC188","DOI":"10.1523\/JNEUROSCI.21-24-j0003.2001","article-title":"Metabotropic glutamate receptors drive the endocannabinoid system in Hippocampus","volume":"21","author":"Varma","year":"2001","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"10100","key":"10.1016\/j.neuropharm.2024.109870_bib77","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.109870_bib78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/7854_2011_192","article-title":"Selectively bred rodents as models of depression and anxiety","volume":"12","author":"Wegener","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109870_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103202","article-title":"Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model","volume":"70","author":"Xu","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109870_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109870_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-ht1a receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109870_bib83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000356517","article-title":"Akt mediates GSK-3\u03b2 phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions","volume":"21","author":"Zhou","year":"2014","journal-title":"Neuroimmunomodulation"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T05:09:35Z","timestamp":1720588175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":82,"alternative-id":["S0028390824000376"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109870","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression.","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109870"}}